MedicalXpress.com-Medical Economics

Despite the large number of patient falls at hospitals, there are few large-scale studies to quantify the cost savings of intervention programs. The Fall TIPS (Tailoring Interventions for Patient Safety) Program is an evidence-based fall […]

Adults living in rural areas of the United States have a 19% higher risk of developing heart failure compared to their urban counterparts, and Black men living in rural areas have an especially higher risk—34%, […]

As the U.S. population ages, the number of people receiving long-term services and supports in their own home has grown, including the use of self-directed care. Self-directed care enables long-term care recipients to hire and […]

When it comes to tobacco control, some states do a far better job than others of preventing and reducing smoking.This post was originally published on this site

Every morning, Luther Moxley helps his partner of 35 years, Wayne Curtis, out of bed and into his wheelchair. Curtis, who has Parkinson’s disease and is partially blind, washes himself seated in the shower, but […]

A new global analysis shows total health-related financial assistance to fight COVID-19 in low- and middle-income countries (LMICs) in the first two years of the pandemic was a record $37.8 billion, which was 810% higher […]

Health care integration has long been touted as a panacea for reining in health care costs and boosting quality of care.This post was originally published on this site

After a decades-long decline—both in terms of financial investment and the overall size of the workforce—the COVID-19 pandemic prompted increased attention and funding for America’s public health systems. This response is typical of the “neglect, […]

A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care. Researchers from the University of Missouri School of Medicine, looked […]

It is a challenging feat to launch a new drug in the market, given the low probability of success during the research and development (R&D) phase and the high costs involved. In recent times, industry […]